{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T12:13:22Z","timestamp":1794399202010,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P01GM051487"],"award-info":[{"award-number":["P01GM051487"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["F32GM122334"],"award-info":[{"award-number":["F32GM122334"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009559","name":"Life Sciences Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type III-A CRISPR-Cas systems are prokaryotic RNA-guided adaptive immune systems that use a protein-RNA complex, Csm, for transcription-dependent immunity against foreign DNA. Csm can cleave RNA and single-stranded DNA (ssDNA), but whether it targets one or both nucleic acids during transcription elongation is unknown. Here, we show that binding of a <jats:italic>Thermus thermophilus (T<\/jats:italic>. <jats:italic>thermophilus<\/jats:italic>) Csm (TthCsm) to a nascent transcript in a transcription elongation complex (TEC) promotes tethering but not direct contact of TthCsm with RNA polymerase (RNAP). Biochemical experiments show that both TthCsm and <jats:italic>Staphylococcus epidermidis<\/jats:italic> (<jats:italic>S. epidermidis<\/jats:italic>) Csm (SepCsm) cleave RNA transcripts, but not ssDNA, at the transcription bubble. Taken together, these results suggest that Type III systems primarily target transcripts, instead of unwound ssDNA in TECs, for immunity against double-stranded DNA (dsDNA) phages and plasmids. This reveals similarities between Csm and eukaryotic RNA interference, which also uses RNA-guided RNA targeting to silence actively transcribed genes.<\/jats:p>","DOI":"10.1038\/s41467-019-10780-2","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T10:03:06Z","timestamp":1562320986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1297-7102","authenticated-orcid":false,"given":"Tina Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek J.","family":"Aditham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-3681","authenticated-orcid":false,"given":"Eva","family":"Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-999X","authenticated-orcid":false,"given":"Jennifer A.","family":"Doudna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"10780_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2015.12.035","volume":"164","author":"AV Wright","year":"2016","unstructured":"Wright, A. V., Nu\u00f1ez, J. K. & Doudna, J. A. Biology and applications of CRISPR systems: harnessing nature\u2019s toolbox for genome engineering. Cell 164, 29\u201344 (2016).","journal-title":"Cell"},{"key":"10780_CR2","doi-asserted-by":"publisher","first-page":"aad5147","DOI":"10.1126\/science.aad5147","volume":"353","author":"P Mohanraju","year":"2016","unstructured":"Mohanraju, P. et al. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science 353, aad5147 (2016).","journal-title":"Science"},{"key":"10780_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova, K. S. et al. An updated evolutionary classification of CRISPR\u2013Cas systems. Nat. Rev. Microbiol. 13, 722\u2013736 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"10780_CR4","doi-asserted-by":"publisher","first-page":"e0176221","DOI":"10.1371\/journal.pone.0176221","volume":"12","author":"HT Ichikawa","year":"2017","unstructured":"Ichikawa, H. T. et al. Programmable type III-A CRISPR-Cas DNA targeting modules. PLoS ONE 12, e0176221 (2017).","journal-title":"PLoS ONE"},{"key":"10780_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature13637","volume":"514","author":"GW Goldberg","year":"2014","unstructured":"Goldberg, G. W., Jiang, W., Bikard, D. & Marraffini, L. A. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514, 633\u2013637 (2014).","journal-title":"Nature"},{"key":"10780_CR6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2015.04.027","volume":"161","author":"P Samai","year":"2015","unstructured":"Samai, P. et al. Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity. Cell 161, 1164\u20131174 (2015).","journal-title":"Cell"},{"issue":"4","key":"10780_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.molcel.2014.10.005","volume":"56","author":"Raymond\u00a0H.J. Staals","year":"2014","unstructured":"Staals, R. H. J. et al. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol. Cell 56, 518\u2013530 (2014).","journal-title":"Molecular Cell"},{"key":"10780_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molcel.2014.09.027","volume":"56","author":"G Tamulaitis","year":"2014","unstructured":"Tamulaitis, G. et al. Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol. Cell 56, 506\u2013517 (2014).","journal-title":"Mol. Cell"},{"key":"10780_CR9","doi-asserted-by":"publisher","first-page":"e0170552","DOI":"10.1371\/journal.pone.0170552","volume":"12","author":"TY Liu","year":"2017","unstructured":"Liu, T. Y., Iavarone, A. T. & Doudna, J. A. RNA and DNA targeting by a reconstituted Thermus thermophilus type III-A CRISPR-Cas system. PLoS ONE 12, e0170552 (2017).","journal-title":"PLoS ONE"},{"key":"10780_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.molcel.2016.03.024","volume":"62","author":"M Kazlauskiene","year":"2016","unstructured":"Kazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, \u010c. & Siksnys, V. Spatiotemporal control of type III-A CRISPR-Cas immunity: coupling DNA degradation with the target RNA recognition. Mol. Cell 62, 295\u2013306 (2016).","journal-title":"Mol. Cell"},{"key":"10780_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1101\/gad.273722.115","volume":"30","author":"MA Estrella","year":"2016","unstructured":"Estrella, M. A., Kuo, F.-T., & Bailey, S. RNA-activated DNA cleavage by the type III-B CRISPR\u2013Cas effector complex. Genes Dev. 30, 460\u2013470 (2016).","journal-title":"Genes Dev."},{"key":"10780_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1101\/gad.272153.115","volume":"30","author":"JR Elmore","year":"2016","unstructured":"Elmore, J. R. et al. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR\u2013Cas system. Genes Dev. 30, 447\u2013459 (2016).","journal-title":"Genes Dev."},{"key":"10780_CR13","first-page":"1983","volume":"45","author":"W Han","year":"2017","unstructured":"Han, W. et al. A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction. Nucleic acids Res. 45, 1983\u20131993 (2017).","journal-title":"Nucleic acids Res."},{"key":"10780_CR14","doi-asserted-by":"publisher","first-page":"27888","DOI":"10.1074\/jbc.M113.499244","volume":"288","author":"A Hatoum-Aslan","year":"2013","unstructured":"Hatoum-Aslan, A., Samai, P., Maniv, I., Jiang, W. & Marraffini, L. A. A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs. J. Biol. Chem. 288, 27888\u201327897 (2013).","journal-title":"J. Biol. Chem."},{"key":"10780_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature02872","volume":"431","author":"CC Mello","year":"2004","unstructured":"Mello, C. C. & Conte, D. Revealing the world of RNA interference. Nature 431, 338\u2013342 (2004).","journal-title":"Nature"},{"key":"10780_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature05932","volume":"448","author":"DG Vassylyev","year":"2007","unstructured":"Vassylyev, D. G., Vassylyeva, M. N., Perederina, A., Tahirov, T. H. & Artsimovitch, I. Structural basis for transcription elongation by bacterial RNA polymerase. Nature 448, 157\u2013162 (2007).","journal-title":"Nature"},{"key":"10780_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cell.2018.10.052","volume":"176","author":"L You","year":"2019","unstructured":"You, L. et al. Structure studies of the CRISPR-Csm complex reveal mechanism of co-transcriptional interference. Cell 176, 239\u2013253.e16 (2019).","journal-title":"Cell"},{"key":"10780_CR18","first-page":"1","volume":"73","author":"N Jia","year":"2018","unstructured":"Jia, N. et al. Type III-A CRISPR-Cas Csm complexes: assembly, periodic RNA cleavage, DNase activity regulation, and autoimmunity. Mol. Cell 73, 1\u201314 (2018).","journal-title":"Mol. Cell"},{"key":"10780_CR19","doi-asserted-by":"publisher","first-page":"e08504","DOI":"10.7554\/eLife.08504","volume":"4","author":"B Bae","year":"2015","unstructured":"Bae, B., Feklistov, A., Lass-Napiorkowska, A., Landick, R. & Darst, S. A. Structure of a bacterial RNA polymerase holoenzyme open promoter complex. eLife 4, e08504 (2015).","journal-title":"eLife"},{"key":"10780_CR20","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1074\/jbc.272.9.5989","volume":"272","author":"D Wang","year":"1997","unstructured":"Wang, D. & Landick, R. Nuclease cleavage of the upstream half of the nontemplate strand DNA in an Escherichia coli transcription elongation complex causes upstream translocation and transcriptional arrest. J. Biol. Chem. 272, 5989\u20135994 (1997).","journal-title":"J. Biol. Chem."},{"key":"10780_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molcel.2015.06.034","volume":"59","author":"CO Barnes","year":"2015","unstructured":"Barnes, C. O. et al. Crystal structure of a transcribing RNA polymerase II complex reveals a complete transcription bubble. Mol. Cell 59, 258\u2013269 (2015).","journal-title":"Mol. Cell"},{"key":"10780_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molcel.2012.04.009","volume":"46","author":"A Aguilera","year":"2012","unstructured":"Aguilera, A. & Garc\u00eda-Muse, T. R loops: from transcription byproducts to threats to genome stability. Mol. Cell 46, 115\u2013124 (2012).","journal-title":"Mol. Cell"},{"key":"10780_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/mmi.12152","volume":"87","author":"L Deng","year":"2013","unstructured":"Deng, L., Garrett, R. A., Shah, S. A., Peng, X. & She, Q. A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol. Microbiol. 87, 1088\u20131099 (2013).","journal-title":"Mol. Microbiol."},{"key":"10780_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1126\/science.aao0100","volume":"357","author":"M Kazlauskiene","year":"2017","unstructured":"Kazlauskiene, M., Kostiuk, G., Venclovas, \u010c., Tamulaitis, G. & Siksnys, V. A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems. Science 357, 605\u2013609 (2017).","journal-title":"Science"},{"key":"10780_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1126\/science.aaa4535","volume":"348","author":"DW Taylor","year":"2015","unstructured":"Taylor, D. W. et al. Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning. Science 348, 581\u2013585 (2015).","journal-title":"Science"},{"key":"10780_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.molcel.2015.03.018","volume":"58","author":"T Osawa","year":"2015","unstructured":"Osawa, T., Inanaga, H., Sato, C. & Numata, T. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Mol. Cell 58, 418\u2013430 (2015).","journal-title":"Mol. Cell"},{"key":"10780_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2017.09.006","volume":"171","author":"TW Guo","year":"2017","unstructured":"Guo, T. W. et al. Cryo-EM structures reveal mechanism and inhibition of DNA targeting by a CRISPR-Cas surveillance complex. Cell 171, 414\u2013426.e12 (2017).","journal-title":"Cell"},{"key":"10780_CR28","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1126\/science.1256996","volume":"345","author":"S Mulepati","year":"2014","unstructured":"Mulepati, S., Heroux, A. & Bailey, S. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science 345, 1479\u20131484 (2014).","journal-title":"Science"},{"key":"10780_CR29","first-page":"7385","volume":"44","author":"ML Luo","year":"2016","unstructured":"Luo, M. L. et al. The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers. Nucleic acids Res. 44, 7385\u20137394 (2016).","journal-title":"Nucleic acids Res."},{"key":"10780_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tim.2016.09.012","volume":"25","author":"G Tamulaitis","year":"2017","unstructured":"Tamulaitis, G., Venclovas, \u010c. & Siksnys, V. Type III CRISPR-Cas immunity: major differences brushed aside. Trends Microbiol. 25, 49\u201361 (2017).","journal-title":"Trends Microbiol."},{"key":"10780_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mib.2017.08.003","volume":"37","author":"NC Pyenson","year":"2017","unstructured":"Pyenson, N. C. & Marraffini, L. A. Type III CRISPR-Cas systems: when DNA cleavage just isn\u2019t enough. Curr. Opin. Microbiol. 37, 150\u2013154 (2017).","journal-title":"Curr. Opin. Microbiol."},{"key":"10780_CR32","doi-asserted-by":"crossref","unstructured":"Niewoehner, O. et al. Type III CRISPR-Cas systems generate cyclic oligoadenylate second messengers to activate Csm6 RNases. Nature 76, 543\u2013548 (2017).","DOI":"10.1101\/153262"},{"key":"10780_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41564-018-0353-x","volume":"4","author":"JT Rost\u00f8l","year":"2019","unstructured":"Rost\u00f8l, J. T. & Marraffini, L. A. Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR\u2013Cas immunity. Nat. Microbiol. 4, 656\u2013662 (2019).","journal-title":"Nat. Microbiol."},{"key":"10780_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/15476286.2018.1493334","volume":"16","author":"K Foster","year":"2019","unstructured":"Foster, K., Kalter, J., Woodside, W., Terns, R. M. & Terns, M. P. The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems. RNA Biol. 16, 449\u2013460 (2019).","journal-title":"RNA Biol."},{"key":"10780_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1128\/JB.01130-13","volume":"196","author":"A Hatoum-Aslan","year":"2014","unstructured":"Hatoum-Aslan, A., Maniv, I., Samai, P. & Marraffini, L. A. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system. J. Bacteriol. 196, 310\u2013317 (2014).","journal-title":"J. Bacteriol."},{"key":"10780_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cell.2015.12.053","volume":"164","author":"W Jiang","year":"2016","unstructured":"Jiang, W., Samai, P. & Marraffini, L. A. Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity. Cell 164, 710\u2013721 (2016).","journal-title":"Cell"},{"key":"10780_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.biochem.73.011303.073859","volume":"74","author":"A Johnson","year":"2005","unstructured":"Johnson, A. & O\u2019Donnell, M. CELLULAR DNA REPLICASES: components and dynamics at the replication fork. Annu. Rev. Biochem. 74, 283\u2013315 (2005).","journal-title":"Annu. Rev. Biochem."},{"key":"10780_CR38","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aav4294","volume":"362","author":"LB Harrington","year":"2018","unstructured":"Harrington, L. B. et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 362, 839\u2013842 (2018).","journal-title":"Science"},{"key":"10780_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aar6245","volume":"360","author":"JS Chen","year":"2018","unstructured":"Chen, J. S. et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360, 436\u2013439 (2018).","journal-title":"Science"},{"key":"10780_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jmb.2006.11.050","volume":"366","author":"A Sevostyanova","year":"2007","unstructured":"Sevostyanova, A. et al. Temporal regulation of viral transcription during development of Thermus thermophilus bacteriophage \u03d5YS40. J. Mol. Biol. 366, 420\u2013435 (2007).","journal-title":"J. Mol. Biol."},{"key":"10780_CR41","doi-asserted-by":"publisher","unstructured":"Liu, X. & Wang, H.-W. Single particle electron microscopy reconstruction of the exosome complex using the random conical tilt method. J. Vis. Exp. e2574 https:\/\/doi.org\/10.3791\/2574 (2011).","DOI":"10.3791\/2574"},{"key":"10780_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jsb.2009.01.002","volume":"166","author":"GC Lander","year":"2009","unstructured":"Lander, G. C. et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 166, 95\u2013102 (2009).","journal-title":"J. Struct. Biol."},{"key":"10780_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang, G. et al. EMAN2: An extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38\u201346 (2007).","journal-title":"J. Struct. Biol."},{"key":"10780_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"10780_CR45","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"10780_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"10780_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"10780_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"10780_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10780_CR50","doi-asserted-by":"crossref","unstructured":"Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. eLife 5, e18722 (2016).","DOI":"10.7554\/eLife.18722"},{"key":"10780_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","volume":"22","author":"K Arnold","year":"2006","unstructured":"Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinforma. (Oxf., Engl.) 22, 195\u2013201 (2006).","journal-title":"Bioinforma. (Oxf., Engl.)"},{"key":"10780_CR52","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.str.2015.01.021","volume":"23","author":"T-Y Jung","year":"2015","unstructured":"Jung, T.-Y. et al. Crystal structure of the Csm1 subunit of the Csm complex and its single-stranded DNA-specific nuclease activity. Structure 23, 782\u2013790 (2015).","journal-title":"Structure"},{"key":"10780_CR53","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/1873-3468.12179","volume":"590","author":"\u010c Venclovas","year":"2016","unstructured":"Venclovas, \u010c. Structure of Csm2 elucidates the relationship between small subunits of CRISPR-Cas effector complexes. FEBS Lett. 590, 1521\u20131529 (2016).","journal-title":"FEBS Lett."},{"key":"10780_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jmb.2014.09.029","volume":"427","author":"T Numata","year":"2015","unstructured":"Numata, T., Inanaga, H., Sato, C. & Osawa, T. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex. J. Mol. Biol. 427, 259\u2013273 (2015).","journal-title":"J. Mol. Biol."},{"key":"10780_CR55","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"10780_CR56","first-page":"1948","volume-title":"Acta Crystallographica Section D Biological Crystallography","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallographica Section D Biological Crystallography 58, (1948\u20131954 (2002)."},{"key":"10780_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10780-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10780-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10780-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:13:14Z","timestamp":1671235994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10780-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10780"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10780-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.D. is a co-founder of Caribou Biosciences, Editas Medicine, Intellia Therapeutics, Scribe Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Synthego, Metagenomi, Mammoth Biosciences, and Inari. J.A.D is a member of the board of directors at Johnson & Johnson, and has sponsored research projects supported by Pfizer, Inc. and Biogen. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3001"}}